No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
519729 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
160 |
4. Check minimum number of eventsNone |
160 |
5. Include endpointsNone |
160 |
6. Filter based on genotype QC (FinnGen only) |
160 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Supernumerary teeth EXCLUDE clefts and syndromes
based on the number of shared cases.
Similar with more cases:
- Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo
- Disorders of tooth development and eruption
- Diseases of oral cavity, salivary glands and jaws
- Gastrointestinal diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3723 | 1455 | 2264 |
| Only index persons | 3237 | 1262 | 1975 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.04 | 0.06 |
| Only index persons | 0.06 | 0.05 | 0.08 |
| Median age at first event (years) | |||
| Whole population | 10.23 | 10.55 | 9.98 |
| Only index persons | 10.76 | 11.25 | 10.45 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 160 | 84 | 76 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 14.46 | 14.38 | 14.55 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 145
- Matched controls
- 1449
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K00.10
ICD-10 Finland
The incisor and canine region, including the mesiodens
2046.3
100.7
86
*
K00.11
ICD-10 Finland
Excess teeth in the premolar region
+∞
24.7
23
*
K00.19
ICD-10 Finland
Indefinite redundant teeth
+∞
23.6
22
*
EBA10
NOMESCO Finland
Surgical removal of tooth
5.3
18.1
71
223
K00.12
ICD-10 Finland
Excess teeth in the molar region
102.1
17.0
18
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
7.4
9.7
23
36
EBA12
NOMESCO Finland
Complicated surgical removal of tooth
6.6
9.4
24
42
K01.0
ICD-10 Finland
Embedded teeth
9.6
9.1
18
21
ECA00
NOMESCO Finland
Surgical exposure of tooth
31.7
7.2
9
*
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
10.8
6.7
12
12
SAA04
NOMESCO Finland
Special inverstigation of mouth
4.1
6.7
26
74
K00.1
ICD-10 Finland
Supernumerary teeth
72.9
6.5
7
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3032080) INR in Blood by Coagulation assay
50
294
2.02
3.86
6.8
4.6
inr
1.1
1.1
0.05
16
104
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
7
13
5.58
2.90
2.1
1.3
umol/l
4.4
5.2
—
7
13
(40760892) CBC W Ordered Manual Differential panel - Blood
45
279
1.85
2.89
3.2
4.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
148
1315
2.67
2.88
13.0
8.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
21
99
2.29
2.79
14.7
6.6
mmol/l
1.1
1.4
0.17
12
67
(3007853) Bacteria identified in Skin by Aerobe culture
25
127
2.15
2.79
1.6
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
52
342
1.77
2.74
2.8
2.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
10
6.18
2.72
1.2
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
13
49
2.80
2.69
1.1
1.5
mg/l
5.6
3.9
—
6
27
(3005719) IgG [Mass/volume] in Serum or Plasma
19
88
2.32
2.63
2.2
3.3
g/l
10.9
10.0
0.28
19
80
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
62
435
1.69
2.58
3.2
2.7
nmol/l
71.8
70.6
0.12
56
397
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
11
5.62
2.56
1.5
7.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
43
273
1.79
2.53
2.9
2.5
ng/l
19.2
38.2
0.47
23
114
(3042936) Bacteria identified in Isolate by Culture
24
125
2.08
2.52
2.1
2.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
22
113
2.10
2.39
1.1
1.3
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
5
8
6.41
2.39
4.8
3.0
umol/l
69.0
45.3
—
5
8
(3013650) Neutrophils [#/volume] in Blood by Automated count
89
702
1.60
2.25
8.9
8.7
e9/l
3.8
4.1
0.60
81
601
(3028026) IgM [Mass/volume] in Serum or Plasma
16
74
2.29
2.23
1.5
2.1
g/l
1.2
1.0
0.47
16
68
(3013115) Eosinophils [#/volume] in Blood
81
626
1.60
2.22
7.9
7.6
e9/l
0.2
0.2
0.02
73
557
(3001604) Monocytes [#/volume] in Blood
79
607
1.60
2.22
7.8
7.0
e9/l
0.5
0.6
0.18
70
522
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
14
61
2.42
2.22
1.8
2.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
15
68
2.33
2.19
2.3
5.6
%
0.2
0.3
—
5
20
(3006315) Basophils [#/volume] in Blood
79
609
1.59
2.17
7.8
6.9
e9/l
0.0
0.0
0.15
70
527
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
139
1236
1.95
2.17
15.8
10.3
mg/l
18.9
20.8
0.30
111
897
(3022313) Gas panel - Capillary blood
16
76
2.23
2.11
17.9
7.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
10
5.12
2.08
1.2
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
82
646
1.55
2.00
7.6
6.8
e9/l
2.1
2.0
0.11
73
577
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
11
4.65
1.95
3.2
7.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
59
434
1.57
1.94
12.8
8.7
mmol/l
1.2
1.2
0.10
51
377
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
28
2.95
1.89
2.8
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
28
2.95
1.89
1.5
4.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
15
73
2.16
1.87
2.3
5.3
%
1.2
0.8
—
5
22
(3002256) Pathology report gross observation
20
110
1.94
1.83
1.3
1.2
—
—
—
0
0
(4034850)
7
23
3.13
1.82
2.0
8.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
55
404
1.55
1.80
2.3
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
69
533
1.52
1.79
5.3
4.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
25
150
1.79
1.76
1.3
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
14
68
2.16
1.76
2.5
4.9
%
0.4
0.5
—
5
17
(3023368) Bacteria identified in Blood by Culture
31
199
1.69
1.74
4.4
4.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
17
90
1.99
1.73
3.8
2.8
%
30.9
30.7
0.03
12
65
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
42
2.47
1.71
1.7
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
55
408
1.53
1.71
8.5
7.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
38
262
1.59
1.62
2.9
2.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
154
1458
2.50
1.62
20.9
14.5
g/l
137.0
138.2
0.49
154
1442
(3035941) MCH [Entitic mass]
154
1457
2.52
1.61
20.7
14.2
pg
29.8
29.8
0.13
154
1440
(3024731) MCV [Entitic volume]
154
1457
2.52
1.61
20.7
14.2
fl
88.9
88.7
0.12
154
1441
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
20
3.08
1.59
3.0
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
94
789
1.46
1.55
5.8
3.7
mm/h
7.5
8.0
0.25
88
731
(3015736) pH of Urine
61
471
1.48
1.55
3.6
2.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
109
943
1.49
1.53
4.7
3.5
pmol/l
14.3
14.6
0.69
102
857
(4306422)
6
21
2.93
1.52
1.0
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
28
2.57
1.47
4.1
4.6
e9/l
3.0
3.7
—
7
28
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
28
2.57
1.47
4.1
4.8
%
46.7
53.6
—
7
28
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
16
3.19
1.45
1.4
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
40
287
1.52
1.43
1.7
1.5
pmol/l
100.4
96.0
0.22
28
154
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
11
53
2.15
1.42
4.4
3.5
mmol/l
1.2
1.2
0.20
11
42
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
16
90
1.86
1.39
22.4
12.7
mmol/l
24.6
24.8
0.09
16
90
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
124
1112
1.51
1.36
5.0
4.0
mu/l
1.9
1.8
0.63
115
1047
(3000991) Gas panel - Venous blood
17
99
1.80
1.33
11.0
13.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
5
115
0.42
1.31
1.2
2.5
mmol/l
2.4
2.4
—
5
102
(4035726)
12
64
1.95
1.21
1.2
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
26
2.36
1.20
1.7
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
113
1008
1.41
1.17
3.2
2.8
mmol/l
5.4
5.6
0.71
106
924
(3027315) Oxygen [Partial pressure] in Blood
5
20
2.55
1.16
5.0
4.4
kpa
9.4
9.5
—
5
20
(3013290) Carbon dioxide [Partial pressure] in Blood
5
20
2.55
1.16
5.0
4.4
kpa
5.2
5.0
—
5
20
(3013512) EKG study
27
186
1.54
1.16
3.9
2.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
31
2.31
1.12
1.4
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
17
106
1.68
1.08
10.0
8.4
mmol/l
0.8
1.6
0.33
17
74
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
7
33
2.17
1.07
9.0
18.7
%
0.6
0.7
—
7
33
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
118
1069
1.40
1.05
3.6
3.1
mmol/l
2.6
2.8
1.61
113
1004
(3012544) pH of Venous blood
17
107
1.66
1.04
10.0
8.5
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
7
34
2.11
1.04
9.0
18.2
%
1.0
1.8
—
7
34
(3017143) Hepatitis C virus Ab [Presence] in Serum
36
270
1.43
1.03
1.9
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
23
2.21
0.98
2.0
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
23
2.21
0.98
4.2
4.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
21
142
1.55
0.98
2.4
2.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
0
31
0.00
0.97
0.0
19.1
—
1.2
—
0
25
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
37
1.93
0.95
1.1
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
103
0.47
0.93
2.4
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
11
63
1.80
0.92
2.1
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
28
2.19
0.92
3.7
2.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
33
249
1.41
0.92
4.9
3.5
ph
7.4
7.4
—
9
39
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
43
340
1.36
0.91
5.4
3.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
111
1006
1.34
0.91
11.2
7.9
ml/min/173m2
104.1
101.9
0.47
83
766
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
87
764
1.30
0.89
10.3
6.0
u/l
94.6
82.1
1.21
81
714
(3029937) Albumin [Presence] in Urine by Test strip
38
296
1.37
0.88
3.9
3.3
estimate
0.2
0.0
0.44
11
112
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
6
30
2.04
0.88
2.5
2.8
%
64.3
49.9
—
6
30
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
14
88
1.65
0.87
1.3
1.5
miu/ml
321.0
279.6
—
5
48
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
39
486
0.74
0.87
2.2
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
17
113
1.56
0.86
1.4
1.3
iu/ml
168.9
115.0
—
6
48
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
137
1288
1.44
0.85
11.5
7.7
u/l
28.1
26.8
0.28
132
1247
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13
82
1.64
0.81
2.2
2.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
15
100
1.55
0.76
1.9
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
34
267
1.35
0.75
2.5
3.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
5
24
2.12
0.75
2.4
2.3
ug/l
92.0
277.1
—
5
24
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
25
2.03
0.73
2.2
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
23
170
1.41
0.72
2.2
3.4
e6/l
0.8
0.8
0.04
13
104
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
40
1.78
0.72
1.6
2.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
26
1.95
0.71
1.0
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
26
1.95
0.71
1.0
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
26
1.95
0.71
1.2
1.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
45
372
1.29
0.70
2.4
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
27
1.88
0.69
1.4
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
19
137
1.44
0.68
14.4
3.6
umol/l
4.6
9.4
0.88
19
116
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
43
1.66
0.67
1.3
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
134
1268
1.35
0.67
13.7
11.4
%
41.1
40.9
0.21
122
1089
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
28
1.81
0.66
2.2
2.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
44
1.62
0.66
1.9
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
51
1.60
0.61
1.8
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
22
0.00
0.60
0.0
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
122
1147
1.27
0.59
15.9
12.8
%
13.3
13.1
0.74
122
1127
(3000494) Fungus identified in Specimen by Culture
14
98
1.47
0.59
2.0
2.0
—
—
—
0
0
(3019225) pH of Specimen
9
61
1.50
0.55
8.7
3.7
—
—
—
0
0
(4010399)
10
66
1.55
0.54
1.1
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
19
144
1.36
0.53
1.7
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
70
627
1.21
0.53
2.0
2.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
50
433
1.23
0.52
2.0
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
40
1.52
0.52
1.7
1.9
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
40
1.52
0.52
1.2
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
36
303
1.24
0.49
4.5
3.7
e6/l
7.8
59.3
1.63
30
234
(3030467) Casts [#/volume] in Urine by Automated count
33
275
1.25
0.49
2.9
3.7
e6/l
0.2
0.3
0.40
24
207
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
37
433
0.81
0.49
2.9
2.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
23
284
0.78
0.47
3.5
2.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
50
1.42
0.45
3.0
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
10
69
1.48
0.45
1.0
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
14
104
1.38
0.45
1.3
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
22
177
1.28
0.43
1.4
1.3
iu/ml
10.3
24.2
—
6
50
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
57
1.42
0.43
3.9
2.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
32
1.58
0.42
1.0
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
45
394
1.20
0.42
1.6
1.5
g/l
2.1
2.0
0.37
31
226
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
33
1.53
0.41
3.2
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
35
300
1.21
0.41
1.7
1.7
—
—
—
0
0
(3003338) MCHC [Mass/volume]
125
1196
1.21
0.40
16.1
12.4
g/l
334.4
335.2
0.54
125
1183
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
36
1.40
0.38
1.0
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
64
583
1.16
0.38
4.7
4.4
estimate
0.0
0.0
0.00
13
114
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
42
474
0.85
0.37
3.0
2.7
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
9
70
1.30
0.37
7.6
17.1
kpa
4.7
5.1
—
9
65
(3027801) Oxygen [Partial pressure] in Arterial blood
9
70
1.30
0.37
7.6
17.1
kpa
16.6
16.1
—
9
65
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
6
42
1.44
0.36
1.2
2.5
ng/l
36.0
94.1
—
6
37
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
10
73
1.39
0.35
4.3
5.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
34
295
1.19
0.35
4.2
3.7
mmol/l
7.6
8.7
0.76
29
266
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
44
1.38
0.35
1.0
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
6
44
1.38
0.35
1.2
2.0
u/l
37.3
36.8
—
6
37
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
46
1.32
0.33
1.5
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
63
579
1.15
0.32
3.8
3.1
estimate
0.0
0.0
0.00
12
112
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
27
232
1.20
0.31
2.9
2.6
mg/l
0.9
1.4
0.50
21
157
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
54
1.31
0.31
1.1
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
20
167
1.23
0.30
2.3
3.6
e6/l
8.1
3.3
0.45
11
101
(40758558) Short blood count panel - Blood
33
290
1.17
0.30
9.0
8.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
54
587
0.88
0.29
12.3
8.8
e9/l
0.0
0.0
0.62
46
467
(3000492) Spirometry study
9
118
0.75
0.28
1.2
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
17
203
0.82
0.28
3.6
3.4
umol/l
302.3
7364.4
1.05
17
185
(3018095) Leukocytes [#/volume] in Urine
43
389
1.14
0.27
5.0
4.2
e6/l
12.7
40.7
1.36
34
248
(3022621) pH of Urine by Test strip
9
73
1.25
0.26
1.7
1.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
63
588
1.12
0.25
3.5
3.2
estimate
0.0
0.0
0.00
14
109
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
136
0.79
0.24
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
35
387
0.88
0.24
2.3
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
28
248
1.16
0.23
2.5
2.4
ug/g
144.1
78.0
0.38
22
187
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
12
97
1.26
0.23
3.9
3.3
%
20.6
21.2
—
5
35
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
93
0.74
0.23
2.1
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
47
433
1.12
0.23
4.1
2.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
21
183
1.17
0.21
1.3
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
80
1.27
0.21
1.1
1.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
13
0.00
0.21
0.0
2.7
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
13
0.00
0.21
0.0
5.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
76
798
0.91
0.20
6.4
3.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
48
1.26
0.20
1.0
1.3
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
19
165
1.17
0.20
1.4
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
14
118
1.20
0.20
2.7
3.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
60
566
1.10
0.18
2.3
2.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
31
282
1.12
0.18
3.1
3.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
20
176
1.16
0.18
1.5
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
8
72
1.12
0.16
2.0
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
16
182
0.87
0.16
1.2
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
90
0.77
0.15
2.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
90
0.77
0.15
2.0
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
49
463
1.08
0.14
2.0
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
21
232
0.89
0.14
3.1
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
20
180
1.13
0.14
1.5
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
30
278
1.10
0.13
1.4
2.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
20
181
1.12
0.13
1.5
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
114
1.15
0.12
1.7
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
95
1.17
0.12
3.5
2.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
19
174
1.10
0.10
5.4
4.2
mg/mmol
5.0
18.5
1.70
12
120
(3016879) Cocaine [Presence] in Urine
15
164
0.91
0.08
1.5
1.7
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
8
75
1.07
0.07
1.8
2.2
—
16.9
—
0
6
(3008898) HLA-B27 [Presence]
7
81
0.86
0.07
1.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
82
0.85
0.07
1.3
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
84
0.83
0.07
1.4
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
90
0.88
0.07
1.6
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
14
152
0.91
0.06
1.4
2.9
ng/l
140.6
342.5
—
7
84
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
109
1.11
0.06
1.7
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
109
1.11
0.06
1.7
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
109
1.11
0.06
1.7
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
10
110
0.90
0.05
2.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
19
179
1.07
0.05
1.5
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
121
1.08
0.04
1.3
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
139
0.93
0.03
1.4
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
17
179
0.94
0.03
1.4
1.3
u/ml
1.0
8.8
—
9
73
(3041096) Erythrocytes [Presence] in Urine by Automated
33
339
0.97
0.02
3.8
2.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
47
461
1.03
0.02
1.5
1.4
u/ml
0.5
1.5
1.93
13
93
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
124
1247
0.98
0.01
3.7
3.9
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
13
126
1.03
0.00
1.8
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
11
109
1.01
0.00
1.7
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
17
171
0.99
0.00
4.5
3.5
mg/l
32.6
111.0
1.66
11
115
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
24
241
1.00
0.00
1.3
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
11
107
1.03
0.00
2.8
2.6
u/l
30.4
27.3
0.18
11
87
(3050129) First trimester maternal screen panel - Serum or Plasma
13
133
0.98
0.00
1.7
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
12
123
0.97
0.00
1.6
2.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
21
213
0.98
0.00
1.7
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
10
95
1.06
0.00
2.0
1.8
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
762.3
—
0
7
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
3.7
—
102.4
—
0
7
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
181.9
—
0
7
(3011648) Oxygen content in Venous blood
0
7
0.00
0.00
0.0
15.9
—
14.6
—
0
7
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
6.2
—
0
7
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
1556.9
—
0
7
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(4211845)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
54
0.92
0.00
1.2
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
7
0.00
0.00
0.0
12.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
6
63
0.95
0.00
7.0
2.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
72
0.97
0.00
1.4
2.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
8.1
—
0
5
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
87.7
—
0
6
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
0
6
0.00
0.00
0.0
1.0
—
1.1
—
0
6
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
51
0.98
0.00
1.0
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
9
94
0.95
0.00
2.1
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
8
0.00
-0.00
0.0
1.6
—
1.9
—
0
8
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint K11_SUPNUM_ONLY and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have K11_SUPNUM_ONLY.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: K11_SUPNUM_ONLY – Supernumerary teeth EXCLUDE clefts and syndromes
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data